News

Safinamide is currently under clinical development by Meiji in Japan. Under the agreement, Eisai will obtain exclusive rights to safinamide to market in Japan and to develop and

FIN-524 is a live biotherapeutic product in pre-clinical research. It is composed of cultured bacterial strains that have been linked to favorable clinical outcomes in studies of microbiota

The trial had assessed the efficacy, safety and tolerability of a single administration of two different doses of Botox, including 30 units (30U) or 50 units (50 U),

The Phase 2a single-dose trial is being conducted in the United Kingdom. The primary objective of this double-blind, placebo-controlled study will evaluate the pharmacokinetic and pharmacodynamics profile and

The Company has retained Stifel, Nicolaus & Company, Incorporated to serve as its financial advisor in the process. Aviragen Therapeutics does not have a defined timeline for the

The study, dubbed OPTIC, assessed the safety and efficacy of once-daily, IV-to-oral omadacycline in comparison to IV-to-oral moxifloxacin in the treatment of CABP in adults. In the clinical trial featuring 774

Imbruvica is an oral and once-daily therapy, which suppresses Bruton's tyrosine kinase (BTK) protein, which is a signaling molecule in the B-cell receptor signaling complex that will spread

Formerly known under the developmental name SD-809, austedo has now become the first deuterated product to get FDA approval and also the second drug approved in HD. Previously

The approval marks the first targeted treatment approved for the patient population, who previously had few treatment options, in all 28 member states of the European Union (EU),